ABL1/2 抗体 (C-Term)
ABL1/ABL2
适用: 人
IHC, WB, IF, ICC
宿主: 兔
Polyclonal
unconjugated
-
- 抗原 See all ABL1/2 (ABL1/ABL2) 抗体
- ABL1/2 (ABL1/ABL2) (Abelson Murine Leukemia Viral Oncogene Homolog 1/2 (ABL1/ABL2))
-
抗原表位
- C-Term
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This ABL1/2 antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC), Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)
- 特异性
- Recognizes endogenous levels of ABL1/2 protein
- 交叉反应 （详细）
- Mouse, Rat
- 产品特性
- Purified Polyclonal ABL1/2 antibody
- 纯化方法
- ABL1/2 antibody was purified by immunogen affinity chromatography
- 免疫原
- ABL1/2 antibody was raised in Rabbit using a KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ABL1/2 as the immunogen
- Top Product
- Discover our top product ABL1/ABL2 Primary Antibody
-
anti-Abelson Murine Leukemia Viral Oncogene Homolog 1/2 (ABL1/ABL2) (Lys5) antibody
ABL1/ABL2 适用: 人, 小鼠 IHC, WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Abelson Murine Leukemia Viral Oncogene Homolog 1/2 (ABL1/ABL2) (C-Term), (pTyr393), (pTyr439) antibodyABL1/ABL2 适用: 人, 小鼠, 大鼠 IHC, WB, IF, IC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB: 1:500 - 1:1000, IHC: 1:100 - 1:200, IF: 1:100 - 1:500, ICC: 1:100 - 1:500
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Supplied in liquid form in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3 with 30 % glycerol and 0.01 % sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 4 deg C for short term storage. For long term, aliquot and store at -20 deg C. Avoid repeat freeze/thaw cycles
-
- 抗原
- ABL1/2 (ABL1/ABL2) (Abelson Murine Leukemia Viral Oncogene Homolog 1/2 (ABL1/ABL2))
- 别名
- ABL1/2 (ABL1/ABL2 产品)
- 别名
- CABL antibody, ABLL antibody, cb272 antibody, ABL proto-oncogene 2, non-receptor tyrosine kinase antibody, c-abl oncogene 2, non-receptor tyrosine kinase antibody, ABL2 antibody, abl2 antibody
-
You are here:
